To access this element change to forms mode OFF
Grant Award View - GA69440
Towards developing dendritic cell therapy for multiple sclerosis based...
GA ID:
GA69440
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
20-Jan-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$132,741.92
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Towards developing dendritic cell therapy for multiple sclerosis based on promoting Mertk signaling
Purpose:
Multiple sclerosis (MS) is a neurological disease resulting from damage to the insulating covering around nerve cells in the brain and spinal cord. This occurs when the immune system, which normally fights infections, starts to attack cells in the nervous system after it is exposed to certain signals. This project will study ways to dampen down this activation, which may lead to new treatments, particularly in a subgroup of MS patients carrying a gene involved in determining immune responses.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2020
Internal Reference ID:
GNT1191292
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA